Abstract
Type 2 diabetes (T2D) in Asian populations is characterized by a lower body mass index (BMI) than in Caucasian cases. This pilot study investigated antidiabetic outcomes after a Roux-en-Y gastric bypass (RYGB) in Asian subjects with T2D and BMI < 30. Fifteen Koreans with poorly controlled T2D and BMI 23–30 underwent RYGB. Two years after RYGB, seven patients achieved HbA1c < 6.5% without medication (target-achieved). The other cases also showed improved glycemic control. The insulin secretory response during an oral glucose tolerance test was significantly restored in the target-achieved group. Postoperative changes in insulin sensitivity and body weight did not differ between these groups. Beta-cell function improvement is an important determinant of the long-term antidiabetic outcomes of RYGB in Asian subjects with BMI < 30.
Original language | English |
---|---|
Pages (from-to) | 541-544 |
Number of pages | 4 |
Journal | Obesity Surgery |
Volume | 27 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2017 Feb 1 |
Externally published | Yes |
Keywords
- Asian
- Beta-cell
- Body mass index
- Gastric bypass
- Type 2 diabetes
ASJC Scopus subject areas
- Surgery
- Endocrinology, Diabetes and Metabolism
- Nutrition and Dietetics